Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: “Symptom Rebound”

Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: “Symptom Rebound”

Nirmatrelvir plus ritonavir (NPR) has been approved for treating mild to moderate COVID-19 in high-risk adults but concerns about rebound effects have limited its use. This study aimed to identify individuals at risk of seeking medical care among high-risk non-hospitalized patients treated with NPR...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashish Bhargava, Susan Szpunar, Mamta Sharma, Louis Saravolatz
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Viruses
Subjects:
Paxlovid
nirmatrelvir–ritonavir
risk factors
predictors
COVID-19
Online Access:https://www.mdpi.com/1999-4915/17/6/782
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items